UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 28, 2010
STRYKER CORPORATION
(Exact name of registrant as specified in its charter)
|
Michigan (State or other jurisdiction of incorporation) |
0-9165 (Commission File Number) |
38-1239739 (IRS Employer Identification No.) |
|
|
|
|
|
2825 Airview Boulevard, Kalamazoo, Michigan (Address of principal executive offices) |
49002 (Zip Code) |
|
|
|
|
|
|
Registrant's telephone number, including area code: 269.385.2600 |
||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement
On October 28, 2010, Stryker Corporation announced it entered into a definitive agreement to acquire the assets of the Neurovascular division of Boston Scientific in an all cash transaction for $1.5 billion, which includes $100 million of milestone payments. The closing of the transaction is subject to expiration or termination of the applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act, similar requirements in other countries, and other customary closing conditions. A copy of the press release announcing the agreement is attached hereto as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits
|
(d) |
Exhibits |
|
|
|
|
|
99.1 Press release dated October 28, 2010 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| STRYKER CORPORATION | |
| Date: November 1, 2010 | /s/ CURT R. HARTMAN |
| Curt R. Hartman | |
| Vice President and Chief Financial Officer |